NO20042575L - Fremgangsmate for vat granulering av azithromycin - Google Patents
Fremgangsmate for vat granulering av azithromycinInfo
- Publication number
- NO20042575L NO20042575L NO20042575A NO20042575A NO20042575L NO 20042575 L NO20042575 L NO 20042575L NO 20042575 A NO20042575 A NO 20042575A NO 20042575 A NO20042575 A NO 20042575A NO 20042575 L NO20042575 L NO 20042575L
- Authority
- NO
- Norway
- Prior art keywords
- azithromycin
- procedure
- aqueous granulation
- granulation
- aqueous
- Prior art date
Links
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title 1
- 229960004099 azithromycin Drugs 0.000 title 1
- 238000005469 granulation Methods 0.000 title 1
- 230000003179 granulation Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34346901P | 2001-12-21 | 2001-12-21 | |
| PCT/IB2002/005338 WO2003053399A2 (en) | 2001-12-21 | 2002-12-09 | Methods for wet granulating azithromycin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20042575L true NO20042575L (no) | 2004-06-18 |
Family
ID=23346249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042575A NO20042575L (no) | 2001-12-21 | 2004-06-18 | Fremgangsmate for vat granulering av azithromycin |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20030190365A1 (ja) |
| EP (1) | EP1455757A2 (ja) |
| JP (1) | JP2005515212A (ja) |
| KR (1) | KR100669279B1 (ja) |
| CN (1) | CN1606433A (ja) |
| AR (1) | AR037931A1 (ja) |
| AU (1) | AU2002353316A1 (ja) |
| BR (1) | BR0215175A (ja) |
| CA (1) | CA2470055A1 (ja) |
| HN (1) | HN2002000376A (ja) |
| IL (1) | IL161259A0 (ja) |
| MX (1) | MXPA04003027A (ja) |
| NO (1) | NO20042575L (ja) |
| NZ (1) | NZ532063A (ja) |
| PA (1) | PA8562101A1 (ja) |
| PE (1) | PE20030588A1 (ja) |
| PL (1) | PL371125A1 (ja) |
| RU (1) | RU2283651C2 (ja) |
| TW (1) | TW200301260A (ja) |
| WO (1) | WO2003053399A2 (ja) |
| ZA (1) | ZA200402586B (ja) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20020231A2 (en) | 2002-03-18 | 2003-12-31 | Pliva D D | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| NZ532707A (en) * | 2001-12-21 | 2006-07-28 | Pfizer Prod Inc | Directly compressible formulations of azithromycin |
| HRP20020614A2 (en) * | 2002-07-22 | 2004-06-30 | PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. | Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
| US20070185194A1 (en) * | 2003-07-01 | 2007-08-09 | Kamal Mehta | Stable oral compositions of azithromycin monohydrate |
| JP2007513147A (ja) | 2003-12-04 | 2007-05-24 | ファイザー・プロダクツ・インク | 押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法 |
| WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
| US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
| RU2331410C2 (ru) | 2003-12-04 | 2008-08-20 | Пфайзер Продактс Инк. | Способ получения фармацевтических мультичастиц |
| WO2005053651A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate compositions with improved stability |
| US7943585B2 (en) | 2003-12-22 | 2011-05-17 | Sandoz, Inc. | Extended release antibiotic composition |
| MXPA06006887A (es) * | 2003-12-23 | 2006-09-04 | Temrel Ltd | Proceso para producir particulas para composiciones farmaceuticas. |
| US7468428B2 (en) | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
| UA95093C2 (uk) * | 2005-12-07 | 2011-07-11 | Нікомед Фарма Ас | Спосіб одержання кальцієвмісної сполуки |
| CN100441196C (zh) * | 2006-12-15 | 2008-12-10 | 北京化工大学 | 一种制备微粉化阿奇霉素的方法 |
| GB0715628D0 (en) * | 2007-08-10 | 2007-09-19 | Generics Uk Ltd | Solid valsartan composition |
| AU2009316876A1 (en) * | 2008-11-20 | 2011-07-07 | Avantor Performance Materials, Inc. | Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient |
| US8106111B2 (en) | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
| RU2403049C1 (ru) * | 2009-06-04 | 2010-11-10 | Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Федерального агентства по здравоохранению и социальному развитию (ГОУВПО ММА им. И.М. Сеченова Росздрава) | Способ получения таблеток эритромицина |
| EP2295037A1 (en) * | 2009-09-11 | 2011-03-16 | Ratiopharm GmbH | Pharmaceutical formulation containing Ribavirin |
| RU2480689C1 (ru) * | 2011-10-26 | 2013-04-27 | Александр Михайлович Муртищев | Способ получения порошкообразных продуктов |
| MX380123B (es) * | 2016-01-27 | 2025-03-11 | Jiangsu Hengrui Medicine Co | Metodo para preparar una composicion farmaceutica que comprende un derivado de quinolina o una sal del mismo. |
| WO2017163170A1 (en) * | 2016-03-21 | 2017-09-28 | Sun Pharmaceutical Industries Limited | Pharmaceutical composition comprising apixaban |
| CN110292567B (zh) * | 2019-05-17 | 2022-02-18 | 北京悦康科创医药科技股份有限公司 | 一种阿奇霉素胶囊的制备方法 |
| CN113088422A (zh) * | 2021-05-18 | 2021-07-09 | 耿艳飞 | 一种荞麦果醋 |
| CN113559073A (zh) * | 2021-07-20 | 2021-10-29 | 海南海神同洲制药有限公司 | 阿奇霉素片剂及其制备方法 |
| CN116930013A (zh) * | 2023-07-28 | 2023-10-24 | 海南卫康制药(潜山)有限公司 | 一种阿奇霉素干混悬剂中原料粒度的测定方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4474768A (en) * | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
| MX12213A (es) * | 1987-07-09 | 1993-05-01 | Pfizer | Metodo de preparacion de dihidrato de azitromicina cristalino |
| WO1989002271A1 (en) * | 1987-09-10 | 1989-03-23 | Pfizer | Azithromycin and derivatives as antiprotozoal agents |
| TW271400B (ja) * | 1992-07-30 | 1996-03-01 | Pfizer | |
| US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
| DE69524214T3 (de) * | 1994-05-06 | 2008-05-15 | Pfizer Inc. | Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe |
| DE19706978A1 (de) * | 1997-02-21 | 1998-08-27 | Ulrich Dr Posanski | Kombinationspräparat für oral applizierbare Antibiotika |
| US6339063B1 (en) * | 1997-09-10 | 2002-01-15 | Merck & Co., Inc. | 9a-azalides as veterinary antimicrobial agents |
| US6245903B1 (en) * | 1998-08-21 | 2001-06-12 | Apotex, Inc. | Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof |
| US6365574B2 (en) * | 1998-11-30 | 2002-04-02 | Teva Pharmaceutical Industries Ltd. | Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof |
| US6703372B1 (en) * | 1999-06-29 | 2004-03-09 | Biochemie S.A. | Macrolides |
| DE60209704T2 (de) * | 2001-05-22 | 2006-11-16 | Pfizer Products Inc., Groton | Neue kristallforme von azithromycin |
| WO2003032922A2 (en) * | 2001-10-18 | 2003-04-24 | Teva Pharmaceutical Industries Ltd. | Stabilized azithromycin compositions |
-
2002
- 2002-12-09 NZ NZ532063A patent/NZ532063A/xx unknown
- 2002-12-09 MX MXPA04003027A patent/MXPA04003027A/es unknown
- 2002-12-09 WO PCT/IB2002/005338 patent/WO2003053399A2/en not_active Ceased
- 2002-12-09 KR KR1020047009808A patent/KR100669279B1/ko not_active Expired - Fee Related
- 2002-12-09 RU RU2004118502/15A patent/RU2283651C2/ru not_active IP Right Cessation
- 2002-12-09 EP EP02788337A patent/EP1455757A2/en not_active Withdrawn
- 2002-12-09 JP JP2003554158A patent/JP2005515212A/ja not_active Withdrawn
- 2002-12-09 IL IL16125902A patent/IL161259A0/xx unknown
- 2002-12-09 PL PL02371125A patent/PL371125A1/xx not_active Application Discontinuation
- 2002-12-09 BR BR0215175-8A patent/BR0215175A/pt not_active IP Right Cessation
- 2002-12-09 CN CNA02825788XA patent/CN1606433A/zh active Pending
- 2002-12-09 AU AU2002353316A patent/AU2002353316A1/en not_active Abandoned
- 2002-12-09 CA CA002470055A patent/CA2470055A1/en not_active Abandoned
- 2002-12-13 PE PE2002001222A patent/PE20030588A1/es not_active Application Discontinuation
- 2002-12-19 AR ARP020105017A patent/AR037931A1/es unknown
- 2002-12-19 HN HN2002000376A patent/HN2002000376A/es unknown
- 2002-12-20 TW TW091136906A patent/TW200301260A/zh unknown
- 2002-12-20 US US10/327,383 patent/US20030190365A1/en not_active Abandoned
- 2002-12-20 PA PA20028562101A patent/PA8562101A1/es unknown
-
2004
- 2004-04-01 ZA ZA200402586A patent/ZA200402586B/en unknown
- 2004-06-18 NO NO20042575A patent/NO20042575L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1455757A2 (en) | 2004-09-15 |
| PA8562101A1 (es) | 2005-02-04 |
| PL371125A1 (en) | 2005-06-13 |
| WO2003053399A2 (en) | 2003-07-03 |
| JP2005515212A (ja) | 2005-05-26 |
| AU2002353316A1 (en) | 2003-07-09 |
| MXPA04003027A (es) | 2004-07-05 |
| RU2283651C2 (ru) | 2006-09-20 |
| TW200301260A (en) | 2003-07-01 |
| PE20030588A1 (es) | 2003-07-08 |
| KR20040073504A (ko) | 2004-08-19 |
| US20030190365A1 (en) | 2003-10-09 |
| CA2470055A1 (en) | 2003-07-03 |
| RU2004118502A (ru) | 2005-04-10 |
| WO2003053399A3 (en) | 2004-05-21 |
| AR037931A1 (es) | 2004-12-22 |
| ZA200402586B (en) | 2005-04-01 |
| NZ532063A (en) | 2006-03-31 |
| IL161259A0 (en) | 2004-09-27 |
| CN1606433A (zh) | 2005-04-13 |
| BR0215175A (pt) | 2004-12-28 |
| HN2002000376A (es) | 2003-02-21 |
| KR100669279B1 (ko) | 2007-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20042680L (no) | Fremgangsmater for fremstilling av O-demetylvenflaxine | |
| NO20035177D0 (no) | Krystallformer av Azithromycin | |
| NO20043110L (no) | Direkte komprimerbare formuleringer av azitromycin | |
| NO20035522D0 (no) | Kinuklidin-substituerte multisykliske heteroaryler for behandling av sykdom | |
| NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
| NO20040027L (no) | Fremgangsmate for fremstillingen av escitalopram | |
| NO20023549D0 (no) | Fremgangsmåte for rensing av 1,2-dikloretan | |
| NO20040292L (no) | Fremgangsmate for fremstilling av 4-aminodifenylamin | |
| NO20040278L (no) | Fremgangsmate for fremstilling av perindopril | |
| FI20011541A0 (fi) | Menetelmä massan valmistamiseksi | |
| NO20032731D0 (no) | Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner | |
| FI20012170A0 (fi) | Menetelmä lauhteiden käsittelemiseksi | |
| NO20042640L (no) | Fremgangsmate for fremstilling av ekinocandinderivater | |
| NO20023445L (no) | Fremgangsmåte for fremstilling av peptider | |
| NO20030515L (no) | Fremgangsmåte for fremstilling av dinapsolin | |
| NO20035586D0 (no) | Fremgangsmåte for fremstilling av cykloheksanol-derivater | |
| NO20031927L (no) | Forbedret fremgangsmåte for fremstilling av gabapentinmellomprodukt | |
| NO20035138D0 (no) | Fremgangsmåte til fremstilling av amorft natriumsilastatin | |
| NO20041193L (no) | Fremgangsmåte til fremstilling av beta-ionylidenacetaldehyd | |
| NO20023702D0 (no) | Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder | |
| FI20012552A0 (fi) | Metallikarbonaatin valmistusmenetelmä | |
| NO20034972L (no) | Behandling av ADHD | |
| NO20010171D0 (no) | Teknisk behandling av tåke | |
| NO20013802D0 (no) | Fremgangsmåte for fremstilling av kitosaner | |
| NO20035273D0 (no) | Fremgangsmåte for fremstilling av 3-aryl-2- hydroksypropionsyrederivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |